Osteoporosis risk factors: Difference between revisions

Jump to navigation Jump to search
(/* Falling risk factors{{cite journal| author=Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S et al.| title=Clinician's Guide to Prevention and Treatment of Osteoporosis. | journal=Osteoporos Int | year= 2014 | volume= 25 | issue= 10...)
 
(One intermediate revision by one other user not shown)
Line 17: Line 17:
* Insufficient [[physical activity]] (lack of [[bone]] remodeling)
* Insufficient [[physical activity]] (lack of [[bone]] remodeling)
* [[Glucocorticoids]] ([[steroid]]-induced [[osteoporosis]])<ref>{{cite book |author=Bone and Tooth Society of Great Britain, National Osteoporosis Society, Royal College of Physicians |title=Glucocorticoid-induced Osteoporosis |year=2003 |publisher=Royal College of Physicians of London |location=London, UK |isbn=1-860-16173-1 | url=http://www.rcplondon.ac.uk/pubs/contents/966c62dd-8011-4f65-a61d-dd0c7fe4fa4b.pdf }}</ref>  
* [[Glucocorticoids]] ([[steroid]]-induced [[osteoporosis]])<ref>{{cite book |author=Bone and Tooth Society of Great Britain, National Osteoporosis Society, Royal College of Physicians |title=Glucocorticoid-induced Osteoporosis |year=2003 |publisher=Royal College of Physicians of London |location=London, UK |isbn=1-860-16173-1 | url=http://www.rcplondon.ac.uk/pubs/contents/966c62dd-8011-4f65-a61d-dd0c7fe4fa4b.pdf }}</ref>  
* [[Proton pump inhibitors]]<ref>{{cite journal | author = {{subst:CURRENTMONTHNAME}} {{subst:CURRENTYEAR}}ang YX, Lewis JD, Epstein S, Metz DC |title=Long-term proton pump inhibitor therapy and risk of hip fracture | journal=JAMA | year=2006 | volume=296 | pages=2947-53 | id=PMID 17190895 }}</ref>
* [[Proton pump inhibitors]]<ref name="pmid17190895">{{cite journal |vauthors=Yang YX, Lewis JD, Epstein S, Metz DC |title=Long-term proton pump inhibitor therapy and risk of hip fracture |journal=JAMA |volume=296 |issue=24 |pages=2947–53 |year=2006 |pmid=17190895 |doi=10.1001/jama.296.24.2947 |url=}}</ref>


===Less common risk factors===
===Less common risk factors===
Line 70: Line 70:
*'''Medical risk factors'''
*'''Medical risk factors'''
**[[Age]]
**[[Age]]
**Medications causing [[sedation]] ([[narcotic]] [[analgesics]], [[anticonvulsants]], and [[psychotropics]])
**Medications causing [[sedation]] ([[narcotic]] [[analgesics]], [[anticonvulsants]], and psychotropics)
**[[Anxiety]] and [[agitation]]
**[[Anxiety]] and [[agitation]]
**[[Orthostatic hypotension]]
**[[Orthostatic hypotension]]

Latest revision as of 16:41, 17 October 2017

Osteoporosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Osteoporosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Life Style Modification
Pharmacotherapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Osteoporosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Osteoporosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Osteoporosis risk factors

CDC on Osteoporosis risk factors

Osteoporosis risk factors in the news

Blogs on Osteoporosis risk factors

Directions to Hospitals Treating Osteoporosis

Risk calculators and risk factors for Osteoporosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]

Overview

Risk factors for osteoporosis disease are of two types, including non-modifiable and modifiable (potentially) factors. Non-modifiable risk factors include age, sex, menopause, and family history. Modifiable (potentially) risk factors include smoking, alcohol consumption, immobility, glucocorticoid abuse, and use of proton pump inhibitor (PPI).

Risk factors for osteoporosis disease

Common risk factors

Less common risk factors

Disorders, Medications, and Behaviors That May Affect Bone Mass

Primary Disorders

Medications

Behaviors

Risk factors for osteoporosis complications

Fracture risk factors

Falling risk factors[10][11]

References

  1. Ojo F, Al Snih S, Ray LA, Raji MA, Markides KS (2007). "History of fractures as predictor of subsequent hip and nonhip fractures among older Mexican Americans". Journal of the National Medical Association. 99 (4): 412–8. PMID 17444431.
  2. Wong PK, Christie JJ, Wark JD (2007). "The effects of smoking on bone health". Clin. Sci. 113 (5): 233–41. doi:10.1042/CS20060173. PMID 17663660.
  3. Bone and Tooth Society of Great Britain, National Osteoporosis Society, Royal College of Physicians (2003). Glucocorticoid-induced Osteoporosis (PDF). London, UK: Royal College of Physicians of London. ISBN 1-860-16173-1.
  4. Yang YX, Lewis JD, Epstein S, Metz DC (2006). "Long-term proton pump inhibitor therapy and risk of hip fracture". JAMA. 296 (24): 2947–53. doi:10.1001/jama.296.24.2947. PMID 17190895.
  5. Shapses SA, Riedt CS (2006). "Bone, body weight, and weight reduction: what are the concerns?". J. Nutr. 136 (6): 1453–6. PMID 16702302.
  6. Staessen JA, Roels HA, Emelianov D, Kuznetsova T, Thijs L, Vangronsveld J, Fagard R (1999). "Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group". Lancet. 353 (9159): 1140–4. PMID 10209978.
  7. Tucker KL, Morita K, Qiao N, Hannan MT, Cupples LA, Kiel DP (2006). "Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: The Framingham Osteoporosis Study". Am. J. Clin. Nutr. 84 (4): 936–42. PMID 17023723.
  8. "Soft drinks in schools". Pediatrics. 113 (1 Pt 1): 152–4. 2004. PMID 14702469.
  9. Petty SJ, O'Brien TJ, Wark JD (2007). "Anti-epileptic medication and bone health". Osteoporosis international. 18 (2): 129–42. doi:10.1007/s00198-006-0185-z. PMID 17091219.
  10. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S; et al. (2014). "Clinician's Guide to Prevention and Treatment of Osteoporosis". Osteoporos Int. 25 (10): 2359–81. doi:10.1007/s00198-014-2794-2. PMC 4176573. PMID 25182228.
  11. Gillespie WJ, Gillespie LD, Parker MJ (2010). "Hip protectors for preventing hip fractures in older people". Cochrane Database Syst Rev (10): CD001255. doi:10.1002/14651858.CD001255.pub4. PMID 20927724.